Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies.
Saved in:
| Title: | Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies. |
|---|---|
| Authors: | Adedeji AO; 1 Department of Safety Assessment, Genentech, A Member of the Roche Group, South San Francisco, CA, USA., Pourmohamad T; 1 Department of Safety Assessment, Genentech, A Member of the Roche Group, South San Francisco, CA, USA., Chen Y; 2 Janssen Research & Development, LLC, San Diego, CA, USA., Burkey J; 3 Critical Path Institute, Tucson, AZ, USA., Betts CJ; 4 IMED Biotech Unit, AstraZeneca, United Kingdom., Bickerton SJ; 4 IMED Biotech Unit, AstraZeneca, United Kingdom., Sonee M; 2 Janssen Research & Development, LLC, San Diego, CA, USA., McDuffie JE; 2 Janssen Research & Development, LLC, San Diego, CA, USA. |
| Source: | International journal of toxicology [Int J Toxicol] 2019 Jan/Feb; Vol. 38 (1), pp. 12-22. Date of Electronic Publication: 2019 Jan 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
